Put New Aimovig for Migraine Prophylaxis Into Perspective

August 2018

You'll hear buzz about Aimovig (AIM-oh-vig, erenumab), a new biologic to PREVENT migraine in adults.

It blocks receptors for calcitonin gene-related peptide (CGRP)...a vasodilator and pain sensitizer that spikes during migraine attacks.

Expect other "CGRP antagonists" to be approved within a few months.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote